InnovAge Holding Corp. Form 8-K Summary
Business Context and Reporting Period
InnovAge Holding Corp. filed a Current Report on Form 8-K dated October 3, 2022. The filing concerns the scheduling of the company’s fiscal year 2023 annual meeting of stockholders and related deadlines for shareholder proposals and director nominations. It does not report quarterly or annual financial results.
- Annual meeting date: December 13, 2022.
- Format: Virtual meeting conducted through remote communication.
- Common stock: Traded on Nasdaq Global Select Market under the symbol INNV.
Financial Metrics and Capital Position
The filing does not provide revenue, profit, cash flow, margins, debt, liquidity, operating metrics, or other financial results.
Material Changes Versus Prior Comparable Period
No operating or financial changes versus a prior comparable period are disclosed. The company stated that the annual meeting date differs by more than 30 days from the anniversary date of the fiscal year 2022 annual meeting.
Guidance, Outlook, Risks, Contingencies, and Unusual Items
Shareholders seeking to submit proposals for inclusion in the annual meeting proxy materials, including director nominations and Rule 14a-8 proposals, were required to deliver them by email to the Corporate Secretary at legal@myinnovage.com by close of business on October 13, 2022.
Proposals must comply with applicable SEC rules and the company’s amended and restated bylaws, including requirements described in the company’s proxy statement filed February 17, 2022. No financial guidance, litigation update, contingency, or unusual transaction is disclosed.
Key Facts for Investors to Verify
- Confirm the December 13, 2022 virtual annual meeting date and access procedures in subsequent proxy materials.
- Review the company’s proxy statement and amended and restated bylaws for applicable proposal and nomination requirements.
- Verify whether any shareholder proposals or director nominations were ultimately submitted by the October 13, 2022 deadline.
- Consult separate periodic filings for InnovAge’s financial performance, liquidity, debt, and operating outlook.